Viewing StudyNCT01513135



Ignite Creation Date: 2024-05-06 @ 12:11 AM
Last Modification Date: 2024-10-26 @ 10:46 AM
Study NCT ID: NCT01513135
Status: COMPLETED
Last Update Posted: 2016-03-04
First Post: 2012-01-17

Brief Title: A Phase Il of a Therapeutic Recombinant Biologically Active HIV-1 Tat Protein Vaccine in HIV-Infected Anti-Tat Negative ARV-Treated Adult Volunteers
Sponsor: Barbara Ensoli MD
Organization: Istituto Superiore di Sanità

Conditions & Keywords Data

Conditions:
Name
HIV Infections
Keywords:
Name View
Therapeutic immunization View
HIV View
HAART-treated View
participants View
Tat protein View